GlassScriptPhysician profile
Michael H Maser
NPI 1215915350
$4,930.68
in general payments reported to CMS, 2019-2025
56 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $833 · 2021: $974 · 2022: $1,192 · 2023: $876 · 2024: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.53 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $806.57 | 2019-2023 | |
| Hologic Sales and Service, LLC | $496.66 | 2019-2023 | Acessa Provu System, Coolseal Generator |
| Novo Nordisk INC | $299.98 | 2020-2023 | Ozempic, Wegovy |
| Myovant Sciences INC. | $279.73 | 2022 | |
| Ethicon US, LLC | $250.38 | 2020-2023 | Stratafix |
| Medicem INC. | $177.35 | 2020-2023 | |
| Baxter Healthcare | $172.33 | 2020-2021 | |
| Lupin INC. | $145.57 | 2019-2020 | |
| Minerva Surgical, INC | $142.49 | 2020-2024 | |
| Covidien LP | $136.97 | 2019-2020 | |
| Amgen INC. | $134.80 | 2019-2022 | |
| Eisai INC. | $125.53 | 2020-2023 | |
| Pfizer INC. | $121.89 | 2021-2023 | |
| Therapeuticsmd, INC. | $101.79 | 2020-2022 | |
| Roche Diagnostics Corporation | $98.78 | 2019-2021 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.